121 related articles for article (PubMed ID: 30038943)
1. Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer.
Cunningham D; Zhang Q; Liu S; Parajuli KR; Nie Q; Ma L; Zhang A; Chen Z; You Z
Am J Clin Exp Urol; 2018; 6(3):114-122. PubMed ID: 30038943
[TBL] [Abstract][Full Text] [Related]
2. Th17 cells promote tumor growth in an immunocompetent orthotopic mouse model of prostate cancer.
Duan Z; Miller HD; Fu X; Ge D; Jin B; Moustafa AA; Lan R; Zhang K; Chen Z; You Z
Am J Clin Exp Urol; 2019; 7(4):249-261. PubMed ID: 31511831
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition.
Zhang Q; Liu S; Parajuli KR; Zhang W; Zhang K; Mo Z; Liu J; Chen Z; Yang S; Wang AR; Myers L; You Z
Oncogene; 2017 Feb; 36(5):687-699. PubMed ID: 27375020
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of prostate cancer growth and metastasis using a PSA luciferase report plasmid in a mouse model.
Mao QQ; Lin YW; Chen H; Yang K; Kong DB; Jiang H
Asian Pac J Trop Med; 2014 Nov; 7(11):879-83. PubMed ID: 25441987
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial injection to create bone metastasis of prostate cancer in mice.
Zhong L; Miller HD; Zhang Y; Jin B; Ge D; You Z
Am J Clin Exp Urol; 2020; 8(4):93-100. PubMed ID: 32929404
[TBL] [Abstract][Full Text] [Related]
8. In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.
Jenkins DE; Yu SF; Hornig YS; Purchio T; Contag PR
Clin Exp Metastasis; 2003; 20(8):745-56. PubMed ID: 14713108
[TBL] [Abstract][Full Text] [Related]
9. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
10. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
Scatena CD; Hepner MA; Oei YA; Dusich JM; Yu SF; Purchio T; Contag PR; Jenkins DE
Prostate; 2004 May; 59(3):292-303. PubMed ID: 15042605
[TBL] [Abstract][Full Text] [Related]
11. Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.
Nasu Y; Bangma CH; Hull GW; Yang G; Wang J; Shimura S; McCurdy MA; Ebara S; Lee HM; Timme TL; Thompson TC
Prostate Cancer Prostatic Dis; 2001; 4(1):44-55. PubMed ID: 12497062
[TBL] [Abstract][Full Text] [Related]
12. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
[TBL] [Abstract][Full Text] [Related]
13. An Optimal Orthotopic Mouse Model for Human Colorectal Cancer Primary Tumor Growth and Spontaneous Metastasis.
Hite N; Klinger A; Hellmers L; Maresh GA; Miller PE; Zhang X; Li L; Margolin DA
Dis Colon Rectum; 2018 Jun; 61(6):698-705. PubMed ID: 29722728
[TBL] [Abstract][Full Text] [Related]
14. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
[TBL] [Abstract][Full Text] [Related]
15. Aminomethylphosphonic acid inhibits growth and metastasis of human prostate cancer in an orthotopic xenograft mouse model.
Parajuli KR; Zhang Q; Liu S; You Z
Oncotarget; 2016 Mar; 7(9):10616-26. PubMed ID: 26840261
[TBL] [Abstract][Full Text] [Related]
16. Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer.
Xu P; Xu N; Guo K; Xu A; Takenaka F; Matsuura E; Liu C; Kumon H; Huang P
Oncotarget; 2016 May; 7(22):33025-34. PubMed ID: 27105511
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats.
Suzuki S; Naiki-Ito A; Kuno T; Punfa W; Long N; Kato H; Inaguma S; Komiya M; Shirai T; Takahashi S
J Toxicol Pathol; 2015 Jan; 28(1):21-6. PubMed ID: 26023257
[TBL] [Abstract][Full Text] [Related]
18. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
19. Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model.
Dzojic H; Cheng WS; Essand M
Cancer Gene Ther; 2007 Mar; 14(3):233-40. PubMed ID: 17053814
[TBL] [Abstract][Full Text] [Related]
20. Metastatic model for human prostate cancer using orthotopic implantation in nude mice.
Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ
J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
